FEATURE: After Relative Obscurity Lynx Starts Reeling in the Deals | GenomeWeb

NEW YORK, April 11 – Microbead maker Lynx Therapeutics seems to have finally succeeded in getting its message out to the market.

Wednesday, the company announced the latest in a recent string of deals for its Megaclone bead technology, used in gene expression studies. This agreement, in which Lynx will genotype RNA from different varieties of the Tilapia fish for Norwegian marine genomics company GenoMar, is the fifth commercial collaboration Lynx has announced since the end of February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."